Skip to main content
. Author manuscript; available in PMC: 2024 Mar 11.
Published in final edited form as: J Control Release. 2021 Mar 27;333:176–187. doi: 10.1016/j.jconrel.2021.03.032

Fig. 5.

Fig. 5.

Effect of AGEs and RAGEs inhibitors on surface ICAM-1 expression. (A) Images of immunostaining. vRAGE-ELP coacervates suppressed ICAM-1 expression in AGE-stimulated cells. Blue: DAPI-stained nuclei. Red: antibody-stained ICAM-1. Scale bar = 20 μm. (B) Cell-based ELISA. vRAGE-ELP significantly reduced the expression of ICAM-1 (p < 0.0001). N = 6. Statistics: One-way ANOVA, Tukey’s test. #### p < 0.0001, **** p < 0.0001. Asterisks indicate comparisons with AGE group. BSA = 100 μg/mL. AGE = 100 μg/mL. vRAGE-ELP = 1 mg/mL. Empty ELP = 1 mg/mL. NAC = 30 mM. Anti-RAGE antibody = 10 μg/mL.